Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Under the 2023 law, the Department of Social Services was not required to cover other GLP-1s like Ozempic and Mounjaro that had not been FDA-approved for treating weight loss, even though theyre approved for other conditions, like type 2 diabetes, and are widely used for weight loss
If the pharmacy tries to bill the beneficiarys regular Medicare Part D plan for a medication that is being accessed through the GLP-1 Bridge Program, the claim may reject because the program is separate from Part D coverage
10.1016/0016-5085(94)90180-5 129 LimK.BurkeS
Dozens of telehealth providers follow the same playbook
US$ 26.09
US$ 29.81
US$ 24.09
US$ 28.74
US$ 24.91
US$ 23.80
US$ 25.69
US$ 27.24
